The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2

Arenaviruses and coronaviruses include several human pathogenic viruses, such as Lassa virus, Lymphocytic choriomeningitis virus (LCMV), SARS-CoV, MERS-CoV, and SARS-CoV-2. Although these viruses belong to different virus families, they possess a common motif, the DED/EDh motif, known as an exonucle...

Full description

Bibliographic Details
Main Authors: Mya Myat Ngwe Tun, Kouichi Morita, Takeshi Ishikawa, Shuzo Urata
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/13/7/1220
_version_ 1797528979598475264
author Mya Myat Ngwe Tun
Kouichi Morita
Takeshi Ishikawa
Shuzo Urata
author_facet Mya Myat Ngwe Tun
Kouichi Morita
Takeshi Ishikawa
Shuzo Urata
author_sort Mya Myat Ngwe Tun
collection DOAJ
description Arenaviruses and coronaviruses include several human pathogenic viruses, such as Lassa virus, Lymphocytic choriomeningitis virus (LCMV), SARS-CoV, MERS-CoV, and SARS-CoV-2. Although these viruses belong to different virus families, they possess a common motif, the DED/EDh motif, known as an exonuclease (ExoN) motif. In this study, proof-of-concept studies, in which the DED/EDh motif in these viral proteins, NP for arenaviruses, and nsp14 for coronaviruses, could be a drug target, were performed. Docking simulation studies between two structurally different chemical compounds, ATA and PV6R, and the DED/EDh motifs in these viral proteins indicated that these compounds target DED/EDh motifs. The concentration which exhibited modest cell toxicity was used with these compounds to treat LCMV and SARS-CoV-2 infections in two different cell lines, A549 and Vero 76 cells. Both ATA and PV6R inhibited the post-entry step of LCMV and SARS-CoV-2 infection. These studies strongly suggest that DED/EDh motifs in these viral proteins could be a drug target to combat two distinct viral families, arenaviruses and coronaviruses.
first_indexed 2024-03-10T10:05:55Z
format Article
id doaj.art-cc08899f505645938b791d8be85f0d04
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T10:05:55Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-cc08899f505645938b791d8be85f0d042023-11-22T01:32:11ZengMDPI AGViruses1999-49152021-06-01137122010.3390/v13071220The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2Mya Myat Ngwe Tun0Kouichi Morita1Takeshi Ishikawa2Shuzo Urata3Department of Virology, Institute of Tropical Medicine and Leading Program, Graduate School of Biomedical Science, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, JapanDepartment of Virology, Institute of Tropical Medicine and Leading Program, Graduate School of Biomedical Science, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, JapanDepartment of Chemistry, Biotechnology and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Korimoto, Kagoshima 890-0065, JapanNational Research Center for the Control and Prevention of Infectious Diseases (CCPID), Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, JapanArenaviruses and coronaviruses include several human pathogenic viruses, such as Lassa virus, Lymphocytic choriomeningitis virus (LCMV), SARS-CoV, MERS-CoV, and SARS-CoV-2. Although these viruses belong to different virus families, they possess a common motif, the DED/EDh motif, known as an exonuclease (ExoN) motif. In this study, proof-of-concept studies, in which the DED/EDh motif in these viral proteins, NP for arenaviruses, and nsp14 for coronaviruses, could be a drug target, were performed. Docking simulation studies between two structurally different chemical compounds, ATA and PV6R, and the DED/EDh motifs in these viral proteins indicated that these compounds target DED/EDh motifs. The concentration which exhibited modest cell toxicity was used with these compounds to treat LCMV and SARS-CoV-2 infections in two different cell lines, A549 and Vero 76 cells. Both ATA and PV6R inhibited the post-entry step of LCMV and SARS-CoV-2 infection. These studies strongly suggest that DED/EDh motifs in these viral proteins could be a drug target to combat two distinct viral families, arenaviruses and coronaviruses.https://www.mdpi.com/1999-4915/13/7/1220Lymphocytic choriomeningitis virus (LCMV)SARS-CoV-2antiviralsexonuclease (ExoN) motifDED/EDh motif
spellingShingle Mya Myat Ngwe Tun
Kouichi Morita
Takeshi Ishikawa
Shuzo Urata
The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2
Viruses
Lymphocytic choriomeningitis virus (LCMV)
SARS-CoV-2
antivirals
exonuclease (ExoN) motif
DED/EDh motif
title The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2
title_full The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2
title_fullStr The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2
title_full_unstemmed The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2
title_short The Antiviral Effect of the Chemical Compounds Targeting DED/EDh Motifs of the Viral Proteins on Lymphocytic Choriomeningitis Virus and SARS-CoV-2
title_sort antiviral effect of the chemical compounds targeting ded edh motifs of the viral proteins on lymphocytic choriomeningitis virus and sars cov 2
topic Lymphocytic choriomeningitis virus (LCMV)
SARS-CoV-2
antivirals
exonuclease (ExoN) motif
DED/EDh motif
url https://www.mdpi.com/1999-4915/13/7/1220
work_keys_str_mv AT myamyatngwetun theantiviraleffectofthechemicalcompoundstargetingdededhmotifsoftheviralproteinsonlymphocyticchoriomeningitisvirusandsarscov2
AT kouichimorita theantiviraleffectofthechemicalcompoundstargetingdededhmotifsoftheviralproteinsonlymphocyticchoriomeningitisvirusandsarscov2
AT takeshiishikawa theantiviraleffectofthechemicalcompoundstargetingdededhmotifsoftheviralproteinsonlymphocyticchoriomeningitisvirusandsarscov2
AT shuzourata theantiviraleffectofthechemicalcompoundstargetingdededhmotifsoftheviralproteinsonlymphocyticchoriomeningitisvirusandsarscov2
AT myamyatngwetun antiviraleffectofthechemicalcompoundstargetingdededhmotifsoftheviralproteinsonlymphocyticchoriomeningitisvirusandsarscov2
AT kouichimorita antiviraleffectofthechemicalcompoundstargetingdededhmotifsoftheviralproteinsonlymphocyticchoriomeningitisvirusandsarscov2
AT takeshiishikawa antiviraleffectofthechemicalcompoundstargetingdededhmotifsoftheviralproteinsonlymphocyticchoriomeningitisvirusandsarscov2
AT shuzourata antiviraleffectofthechemicalcompoundstargetingdededhmotifsoftheviralproteinsonlymphocyticchoriomeningitisvirusandsarscov2